
Chandan Healthcare Ltd is Rated Sell
2026-06-02 10:10:03Chandan Healthcare Ltd is currently rated Sell by MarketsMOJO, with this rating last updated on 30 May 2026. While the rating was assigned on that date, the analysis and financial metrics discussed here reflect the stock’s current position as of 02 June 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Chandan Healthcare Q4 FY26: Strong Profit Growth Masks Margin Pressure
2026-06-01 19:19:08Chandan Healthcare Ltd., a North India-based diagnostic services provider operating pathology and radiology testing facilities, reported its March quarter (Q4 FY26) results with consolidated net profit surging 64.76% year-on-year to ₹6.92 crores. However, the micro-cap company with a market capitalisation of ₹565.00 crores witnessed its stock tumble 6.02% following the results announcement, closing at ₹228.70 on June 01, 2026, as investors focused on sequential margin contraction despite robust topline expansion.
Read full news articleCorporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






